Does AXITINIB Cause Ejection fraction decreased? 32 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Ejection fraction decreased have been filed in association with AXITINIB (INLYTA). This represents 0.2% of all adverse event reports for AXITINIB.
32
Reports of Ejection fraction decreased with AXITINIB
0.2%
of all AXITINIB reports
4
Deaths
18
Hospitalizations
How Dangerous Is Ejection fraction decreased From AXITINIB?
Of the 32 reports, 4 (12.5%) resulted in death, 18 (56.3%) required hospitalization, and 2 (6.3%) were considered life-threatening.
Is Ejection fraction decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AXITINIB. However, 32 reports have been filed with the FAERS database.
What Other Side Effects Does AXITINIB Cause?
Death (2,222)
Diarrhoea (2,187)
Fatigue (1,816)
Neoplasm progression (1,315)
Hypertension (1,146)
Off label use (1,075)
Nausea (955)
Decreased appetite (920)
Dysphonia (871)
Disease progression (768)
What Other Drugs Cause Ejection fraction decreased?
SACUBITRIL\VALSARTAN (2,551)
TRASTUZUMAB (1,579)
DOXORUBICIN (834)
CYCLOPHOSPHAMIDE (754)
PERTUZUMAB (644)
DOCETAXEL (520)
PACLITAXEL (466)
BISOPROLOL (314)
RITUXIMAB (296)
CARVEDILOL (284)
Which AXITINIB Alternatives Have Lower Ejection fraction decreased Risk?
AXITINIB vs AZACITIDINE
AXITINIB vs AZATHIOPRINE
AXITINIB vs AZD-1222
AXITINIB vs AZELAIC ACID
AXITINIB vs AZELASTINE